参考文献/References:
[1]Fan L,Strasser WK,Li JJ,et al.Breast cancer in China[J].LancetOncol,2014,15(7):e279-e289.
[2]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015 [J].CA Cancer J Clin,2016,66(2):115-132.
[3]王益民,吴奎,诸禹平,等.EGFL7和VEGF在肾透明细胞癌血管生成及转移中的相关性研究及临床意义[J].临床泌尿外科杂志,2010,26(10):732-735.
[4]Hansen TF,Nielsen BS,Sorensen FB,et al.Epidermal growth factor-like domain 7 predicts response to first-line chemotherapy and bevacizumab in patients with metastatic colorectal cancer [J].Molecular Cancer Therapeutics,2014,13(9):2238-2245.
[5]Luo BH,Xiong F,Wang JP,et al.Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling,epithelial-mesenchymal transition,and metastasis of gastric cancer cells[J].PLoS One,2014,9(6):e99922.
[6]Shen X,Han Y,Xue X,et al.Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma[J].Biomedicine and Pharmacotherapy,2016(77):167-175.
[7]Wang F,Kang CS,Wang-Gou SY,et al.EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma[J].Cancer Letters,2017(384):9-18.
[8]Wu F,Yang LY,Li Y,et al.Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma[J].Hepatology,2009,50(6):1839-1850.
[9]Fitch MJ,Campagnolo L,Kuhnert F,et al.Egfl7,a novel epidermal growth factor-domain gene expressed in endothelial cells[J].Developmental Dynamics,2004,230(2):316-324.
[10]Soncin F,Mattot V,Lionneton F,et al.VE-statin,an endothelial repressor of smooth muscle cell migration[J].EMBO Journal,2003,22(21):5700-5711.
[11]Doliana R,Bot S,Bonaldo P,et al.EMI,a novel cysteine-rich domain of EMILINs and other extracellular proteins,interacts with the gC1q domains and participates in multimerization[J]. FEBS Letters,2000,484(2):164-168.
[12]Li Z,Xue TQ,Yang C,et al.EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling[J]. J Cell Biochem,2018,119(12):10327-10337.
[13]Schmidt M,Paes K,De MA,et al.EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution[J].Development,2007,134(16):2913-2923.
[14]Chim SM,Tickner J,Chow ST,et al.Angiogenic factors in bone local environment[J].Cytokine and Growth Factor Reviews,2013,24(3):297-310.
[15]d′Audigier C,Susen S,Blandinieres A,et al.Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells[J].Stem Cell Rev,2018,14(1):82-91.
[16]Lacko LA,Hurtado R,Hinds S,et al.Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function[J].Development, 2017,144(13):2469-2479.
[17]Fan C,Yang LY,Wu F,et al.The expression of Egfl7 in human normal tissues and epithelial tumors [J].Int J Biol Markers,2013,28(1):71-83.
[18]刘学锋,张峰,詹运洪,等.膀胱尿路上皮癌组织中EGFL7蛋白的表达及微血管密度的意义[J].现代肿瘤医学,2016,24(21):3422-3424.
[19]赵燕恋,卢永田,杨继红.鼻咽癌EGFL7 的表达与肿瘤侵袭转移的关系[J].山东大学耳鼻喉眼学报,2015,29(6):31-35.
[20]Garcia-Carbonero R,van Cutsem E,Rivera F,et al.Randomized Phase II Trial of Parsatuzumab(Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer[J].Oncologist,2017,22(4):375 -e30.
[21]Zhang Y,Yang P,Sun T,et al.miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis[J].Nature Cell Biology,2013, 15(3):284-294.
[22]Deng QJ,Xie LQ,Li H.Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression[J].Life Sci,2016(157):38-44.
[23]Shen X,Han Y,Xue X,et al.Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma[J].Biomed Pharmacother,2016(77):167-175.
[24]Diane P,Geraldine PL,Marie CB.High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer[J].Oncol Lett,2016,12(2): 1422-1428.
[25]Campagnolo L,Telesca C,Massimiani M,et al.Different expression of VEGF and EGFL7 in human hepatocellular carcinoma[J].Dig Liver Dis,2016,48(1):76-80.
[26]Johnson L,Huseni M,Smyczek T,et al.Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy[J].Journal of Clinical Investigation,2013,123(9):3997-4009.
[27]刘志勇,欧阳忠,邹小明.EGFL7基因沉默对裸鼠乳腺癌血管生成的影响[J].国际免疫学杂志,2010,33(6):476-480.
[28]Fan C,Yang LY,Wu F,et al.The expression of Egfl7 in human normal tissues and epithelial tumors [J].Int J Biol Markers,2013,28(1):71-83.
[29]Ha SA,Lee YS,Kim HK,et al.The prognostic potential of keratin 18 in breast cancer associated with tumor dedifferentiation,and the loss of estrogen and progesterone receptors[J].Cancer Biomark,2011,10(5):219-231.
[30]李艳琴.女性原发性乳腺癌120例临床病理分析[J].医学信息,2011,24(7):4739-4740.
[31]Delfortrie S,Pinte S,Mattot V,et al.Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation[J].Cancer Res,2011,71(23):7176-7186.
[32]Wang YL,Dong FL,Yang J,et al.Suppression of the epidermal growth factor-like domain 7 and inhibition of migration and epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells[J].Asian Pacific Journal of Cancer Prevention,2015,16(9):4065-4069.
[33]Philippin LG,Baranzelli MC,Samson C,et al.Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer[J].International Journal of Oncology,2013,42(4):1367-1375.
[34]Zhu N,Zhang DZ,Xie HP,et al.Endothelial-specific intron-derived miR-126 is down-regulatedin human breast cancer and targets both VEGFA and PIK3R2[J].Mol Cell Biochem,2011, 351(1-2):157-164.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(23):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(23):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(23):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(23):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(23):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(23):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(23):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(23):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[10]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(23):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]